{
    "clinical_study": {
        "@rank": "102569", 
        "arm_group": [
            {
                "arm_group_label": "DDAVP", 
                "arm_group_type": "Experimental", 
                "description": "Arm receiving DDAVP prior to the operation.  Drug is administered intravenously at .3mcg per kg, over 30 minutes prior to the operation."
            }, 
            {
                "arm_group_label": "No DDAVP", 
                "arm_group_type": "No Intervention", 
                "description": "Patients Will not receive DDAVP prior to Rhinoplasty"
            }
        ], 
        "brief_summary": {
            "textblock": "This is study looking at the use of a medication, Desmopressin acetate (DDAVP), to reduce\n      bleeding, swelling, and bruising in patients undergoing cosmetic nose surgery.  DDAVP is a\n      drug used in patients with bleeding disorders.  It works by activating molecules in the\n      blood stream called platelets that promote clotting.  In the study, participants who are\n      have cosmetic nose surgery (rhinoplasty) will be randomly assigned to receive or not receive\n      medication.  Photographs taken before and shortly after surgery will be evaluated for the\n      amount of bruising and swelling.  Patients with heart, lung, kidney, or liver problems are\n      not eligible to participate."
        }, 
        "brief_title": "DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Postoperative Ecchymosis", 
        "condition_browse": {
            "mesh_term": "Ecchymosis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Undergoing Rhinoplasty where nasal bone osteotomy is necessary\n\n        Exclusion Criteria:\n\n          -  Heart Disease\n\n          -  Renal Disease with decreased GFR\n\n          -  Liver Disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01982760", 
            "org_study_id": "07-10-21"
        }, 
        "intervention": {
            "arm_group_label": "DDAVP", 
            "description": "Patients Receiving DDAVP prior to operation", 
            "intervention_name": "DDAVP", 
            "intervention_type": "Drug", 
            "other_name": "Desmopressin"
        }, 
        "intervention_browse": {
            "mesh_term": "Deamino Arginine Vasopressin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Rhinoplasty", 
            "Ecchymosis", 
            "Edema"
        ], 
        "lastchanged_date": "November 14, 2013", 
        "location": {
            "contact": {
                "email": "bahman.guyuron@uhhospitals.org", 
                "last_name": "Bahman Guyuron, MD", 
                "phone": "440-461-7999"
            }, 
            "facility": {
                "address": {
                    "city": "Lyndhurst", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "44124"
                }, 
                "name": "Lyndhurst Surgery Center"
            }, 
            "investigator": {
                "last_name": "Bahman Guyuron, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Trial for the Use of DDAVP in the Reduction of Post-operative Ecchymosis in Rhinoplasty.", 
        "overall_official": {
            "affiliation": "University Hospitals", 
            "last_name": "Bahman Guyuron, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Photographs taken preoperatively at 1 day and 8 days post-operatively will be analyzed for bruising", 
            "measure": "Reduction in Ecchymosis and Swelling", 
            "safety_issue": "No", 
            "time_frame": "surgery to 8 days post-operatively"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01982760"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospitals of Cleveland", 
            "investigator_full_name": "Bahman Guyuron", 
            "investigator_title": "MD, FAC, Chair of Department of Plastic Surgery", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Looking at the time it takes for patients to feel comfortable wearing makeup, going out in public, and returning to work", 
            "measure": "Patient Behavior Factors", 
            "safety_issue": "No", 
            "time_frame": "Surgery to 3 weeks post-operatively"
        }, 
        "source": "University Hospitals of Cleveland", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospitals of Cleveland", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}